Current status: Answered by Humza Yousaf on 17 June 2021
To ask the Scottish Government what evidence is available to demonstrate that the benefits of vaccinating under-30s outweigh the risks, given that the vaccines that may be used for this are still undergoing trials.
The Medicines and Healthcare products Regulatory Agency (MHRA), which is the UK body responsible for ensuring that medicines and medical devices work and are acceptably safe, and the Joint Committee on Vaccination and Immunisation (JCVI), an independent clinical group of experts that provides all Governments in the UK with advice on vaccinations, both concur that the evidence shows that, overall, the benefits of vaccination, including vaccinating the under 30 year olds, outweigh the risks. In coming to this conclusion, both organisations looked in detail at all the evidence from the clinical trials undertaken by the pharmaceutical companies and the post-approval authorisation monitoring of the vaccines. The JCVI also reviewed and took into consideration the latest available evidence on the current UK COVID-19 infection rate, the scale and pace of the vaccine programme and modelling of the timing and size of any likely third pandemic wave. It is important that all those who are eligible and advised to be vaccinated take up the offer of a vaccine, and complete the course for maximum protection.